Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › cefazolin

cefazolin

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of cefazolin

14 trials tracked of cefazolin: 7 in phase 3 or 4 and 2 with published results. The most-cited published study has 135 citations.

14Trials tracked
7Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 7 Phase 2 2 Phase 1 1 Other / NA 4
  1. Phase 4 Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI) Completed · 135 cited
  2. Phase 4 Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS) Completed · 7 cited
  3. Phase 4 The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI) Completed
  4. Phase 4 Increased Cefazolin During Cesarean Delivery in Obese Population Completed
  5. Phase 4 Preoperative Antibiotics for Carpal Tunnel Release Surgery Completed
  6. Phase 4 Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair Completed
Show 8 more trials
  1. Phase 4 Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Completed
  2. Phase 2 Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions Completed
  3. Phase 2 DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia Completed
  4. Phase 1 Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term Completed
  5. N/A Antibiotic Prophylaxis in Orthopaedic Traumatology Completed
  6. N/A Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty? Completed
  7. N/A The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures Completed
  8. N/A Checklist to Prevent MRSA Surgical Site Infections Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cefazolin shows potential for reduced acute kidney injury in patients with MSSA bacteremia
Infectious Disease RCT
Cefazolin shows potential for reduced acute kidney injury in patients with MSSA bacteremia Cefazolin Shows Potential for Treating MSSA Bacteremia in Adults
This review evaluated intravenous cefazolin compared to other antistaphylococcal penicillins for treating adults with MSSA bacteremia. The a…
Cefazolin may offer a safer option for treating certain blood infections, showing a lower risk of kidney issues in a recent review of clinic…
medRxiv Oct 14, 2026
Meta-analysis shows lower prosthetic joint infection odds with cephalosporins versus non-cephalosporin prophylaxis in primary arthroplasty
Infectious Disease Meta-analysis
Meta-analysis shows lower prosthetic joint infection odds with cephalosporins versus non-cephalosporin prophylaxis in primary arthroplasty Cephalosporins lower prosthetic joint infection risk in primary hip and knee replacements
This systematic review and meta-analysis evaluated single-agent cephalosporin prophylaxis against non-cephalosporin antibiotics in adults un…
A large review of over 200,000 surgeries found lower infection rates when using cephalosporins for prevention.
May 21, 2026
Meta-analysis links ceftriaxone to higher 30-day mortality in MSSA bloodstream infections
Infectious Disease Meta-analysis
Meta-analysis links ceftriaxone to higher 30-day mortality in MSSA bloodstream infections Ceftriaxone May Increase Death Risk In Bloodstream Infections
This meta-analysis of observational studies (2568 patients) found that ceftriaxone was associated with increased 30-day all-cause mortality …
Doctors should stop using ceftriaxone for bloodstream infections because it may raise the risk of dying within the first month of treatment.
May 11, 2026
Systematic review and meta-analysis shows cefotiam reduces postoperative infection in clean surgery
Infectious Disease Meta-analysis
Systematic review and meta-analysis shows cefotiam reduces postoperative infection in clean surgery Cefotiam cuts post-surgery infection risk by half compared to no antibiotics
This systematic review and meta-analysis evaluated cefotiam prophylaxis versus no antibiotic prophylaxis or other beta-lactam agents in adul…
A large review found cefotiam lowers infection risk after clean surgery. It works as well as other common antibiotics without causing more s…
May 1, 2026